Obagi Medical Partners with Schweiger Dermatology for Innovative Aesthetics Leadership Program
Published: 23 Mar 2026
Author: Precedence Research
Obagi Medical, part of Waldencast plc, has partnered with Schweiger Dermatology for the Aesthetics Leadership with Obagi’s Hyaluronic Acid (ALOHA) Program. Schweiger Dermatology will assist in producing real-world data, translating the clinical safety and efficacy from the FDA pivotal trials into everyday practice.
The ALOHA Program includes a Phase 4 clinical study and a real-world evaluation that seeks to enhance patient satisfaction and strengthen relationships in Schweiger's network.
Director of Cosmetic Dermatology and Clinical Research at Schweiger Dermatology, Dr David Goldberg, stated that the partnership aligns with their evidence-based approach to introducing the injectable. He also added that Schweiger’s clinical depth and scale will help evaluate how trial data translates into real-world outcomes across their patient base.
According to Towards Healthcare, the hyaluronic acid market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 12.4 billion in 2026 to approximately USD 23.65 billion by 2035, representing a compound annual growth rate (CAGR) of 7.44% from 2026 to 2035. Partnership with Schweiger Dermatology enhances Obagi's credibility and reach in the aesthetic dermatology market, leveraging Schweiger's extensive patient base and clinical expertise.
About Obagi Medical
Obagi Medical is an industry-leading advanced skincare line rooted in research and skin biology. It is the fastest-growing professional skincare brand in the U.S. in 2024. Initially, it is known for its leadership in the treatment of hyperpigmentation, also empowers individuals to achieve healthy, beautiful skin.
About Schweiger Dermatology
Schweiger Dermatology is a leading national dermatology practice, providing medical, cosmetic, and surgical dermatology, as well as allergy services through Schweiger Allergy. Its main focus is on convenience, timely appointments, and clinical excellence. The practice makes expert skin and allergy care easier to get—often within days, with same-day and next-day appointments available.
About Waldencast plc
Waldencast has a vision-built brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand’s distinct DNA. It is founded by Michel Brousset and Hind Sebti and has the ambition to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth, purpose-driven brands.
A recent report by Towards Healthcare highlights that the hyaluronic acid market, the ALOHA Program will be presented at industry conferences, offering Obagi visibility and positioning as a leader in introducing data-driven aesthetic solutions.